Cempra’s Solithromycin Demonstrates No QT Effects in Thorough QT Study

[GlobeNewswire] – CHAPEL HILL, N.C. — Cempra, Inc. , a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, … more

View todays social media effects on CEMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Cempra is hiring next, click here to view